Morpholine and thiomorpholine tachykinin receptor antagonists
US6048859A · kind A · utility
9Cited by
24References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 1999 |
| Grant date | Apr 11, 2000 |
| Priority date | — |
| Expiry date | Feb 16, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substituted heterocycles of the general structural formula: ##STR1## are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, asthma and emesis, and calcium channel blockers useful in the treatment of cardiovascular conditions such as angina, hypertension or ischemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.